Unsafe and potentially safe herbal therapies are discussed. The use of herbal therapies is on the rise in the United States, but most pharmacists are not adequately prepared educationally to meet patients' requests for information on herbal products. Pharmacists must also cope with an environment in which there is relatively little regulation of herbal therapies by FDA. Many herbs have been identified as unsafe, including borage, calamus, coltsfoot, comfrey, life root, sassafras, chaparral, germander, licorice, and ma huang. Potentially safe herbs include feverfew, garlic, ginkgo, Asian ginseng, saw palmetto, St. John's wort, and valerian. Clinical trials have been used to evaluate feverfew for migraine prevention and rheumatoid arthritis; garlic for hypertension, hyperlipidemia, and infections; ginkgo for circulatory disturbances and dementia; ginseng for fatigue and cancer prevention; and saw palmetto for benign prostatic hyperplasia. Also studied in formal trials have been St. John's wort for depression and valerian for insomnia. The clinical trial results are suggestive of efficacy of some herbal therapies for some conditions. German Commission E, a regulatory body that evaluates the safety and efficacy of herbs on the basis of clinical trials, cases, and other scientific literature, has established indications and dosage recommendations for many herbal therapies. Pharmacists have a responsibility to educate themselves about herbal therapies in order to help patients discern the facts from the fiction, avoid harm, and gain what benefits may be available.

 

This article has been cited by other articles:

				V. W. Leung, S. J Shalansky, M. K Lo, and E. A Jadusingh Prevalence of Use and the Risk of Adverse Effects Associated with Complementary and Alternative Medicine in a Cohort of Patients Receiving Warfarin Ann. Pharmacother., May 1, 2009; 43(5): 875 - 881. [Abstract] [Full Text] [PDF]

				C.-F. Chen and C.-H. Cheng Regulation of Cellular Metabolism and Cytokines by the Medicinal Herb Feverfew in the Human Monocytic THP-1 Cells Evid. Based Complement. Altern. Med., March 1, 2009; 6(1): 91 - 98. [Abstract] [Full Text] [PDF]

				S. P. Dunn, B. Bleske, M. Dorsch, T. Macaulay, B. Van Tassell, and O. Vardeny Nutrition and Heart Failure: Impact of Drug Therapies and Management Strategies Nutr Clin Pract, February 1, 2009; 24(1): 60 - 75. [Abstract] [Full Text] [PDF]

				M. F. P. L. Gomes, C. de Oliveira Massoco, J. G. Xavier, and L. V. Bonamin Comfrey (Symphytum Officinale. L.) and Experimental Hepatic Carcinogenesis: A Short-term Carcinogenesis Model Study Evid. Based Complement. Altern. Med., December 26, 2007; (2007) nem172v1. [Abstract] [Full Text] [PDF]

				L. Howell, K. Kochhar, R. Saywell Jr, T. Zollinger, J. Koehler, C. Mandzuk, B. Sutton, J. Sevilla-Martir, and D. Allen Use of Herbal Remedies by Hispanic Patients: Do They Inform Their Physician? J Am Board Fam Med, November 1, 2006; 19(6): 566 - 578. [Abstract] [Full Text] [PDF]

				P. M. Stavro, M. Woo, L. A. Leiter, T. F. Heim, J. L. Sievenpiper, and V. Vuksan Long-Term Intake of North American Ginseng Has No Effect on 24-Hour Blood Pressure and Renal Function Hypertension, April 1, 2006; 47(4): 791 - 796. [Abstract] [Full Text] [PDF]

				H. Diener, V Pfaffenrath, J Schnitker, M Friede, H-H H.-v. Zepelin, and on behalf of the Investigators Efficacy and Safety of 6.25 mg t.i.d. Feverfew CO2-Extract (MIG-99) in Migraine Prevention -- A Randomized, Double-Blind, Multicentre, Placebo-Controlled Study Cephalalgia, November 1, 2005; 25(11): 1031 - 1041. [Abstract] [Full Text] [PDF]

				K N Woodward The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products Human and Experimental Toxicology, May 1, 2005; 24(5): 219 - 233. [Abstract] [PDF]

				D. Hann, F. Baker, M. Denniston, and N. Entrekin Long-term Breast Cancer Survivors' Use of Complementary Therapies: Perceived Impact on Recovery and Prevention of Recurrence Integr Cancer Ther, March 1, 2005; 4(1): 14 - 20. [Abstract] [PDF]

				C. C. Peng, P. A. Glassman, L. E. Trilli, J. Hayes-Hunter, and C. B. Good Incidence and Severity of Potential Drug-Dietary Supplement Interactions in Primary Care Patients: An Exploratory Study of 2 Outpatient Practices Arch Intern Med, March 22, 2004; 164(6): 630 - 636. [Abstract] [Full Text] [PDF]

				L. G. Costa, L. Steardo, and V. Cuomo Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects Pharmacol. Rev., March 1, 2004; 56(1): 103 - 147. [Abstract] [Full Text] [PDF]

				J. D. Estes, D. Stolpman, A. Olyaei, C. L. Corless, J. M. Ham, J. M. Schwartz, and S. L. Orloff High Prevalence of Potentially Hepatotoxic Herbal Supplement Use in Patients With Fulminant Hepatic Failure Arch Surg, August 1, 2003; 138(8): 852 - 858. [Abstract] [Full Text] [PDF]

				C. Pharand, M. L Ackman, C. A Jackevicius, F. L Paradiso-Hardy, and G. J Pearson Use of OTC and Herbal Products in Patients with Cardiovascular Disease Ann. Pharmacother., June 1, 2003; 37(6): 899 - 904. [Abstract] [Full Text] [PDF]

				J. Ness, D. Johnson, and N. Nisly "Polyherbacy": Herbal Supplements as a Form of Polypharmacy in Older Adults J Gerontol A Biol Sci Med Sci, May 1, 2003; 58(5): M478 - M478. [Full Text] [PDF]

				C. A. Heyneman Preoperative Considerations: Which Herbal Products Should Be Discontinued Before Surgery? Crit. Care Nurse, April 1, 2003; 23(2): 116 - 124. [Full Text] [PDF]

				M. K. Bedi and P. D. Shenefelt Herbal Therapy in Dermatology Arch Dermatol, February 1, 2002; 138(2): 232 - 242. [Abstract] [Full Text] [PDF]

				I. G. Carabin, G. A. Burdock, and C. Chatzidakis Safety Assessment of Panax Ginseng International Journal of Toxicology, July 1, 2000; 19(4): 293 - 301. [Abstract] [PDF]